Updated August 2025
The conversation around Alzheimer’s detection has grown significantly in recent years, and one tool continues to draw attention: the Self-Administered Gerocognitive Examination (SAGE test). This short, pen-and-paper assessment has been studied for more than a decade and remains a valuable conversation starter between families and doctors when memory concerns arise.
What Is the SAGE Test?
The SAGE test was developed at Ohio State University and includes 22 questions that take about 10–15 minutes to complete. The questions measure areas such as:
- Memory and recall
- Problem-solving
- Orientation to date and time
- Language abilities
- Three-dimensional construction
Sample tasks include:
- Listing 12 different animals
- Drawing a clock with the correct numbers and time
- Identifying today’s date
- Explaining how two items (like a bike and train) are similar
Missing six or more questions may indicate the need for further evaluation by a physician.
Why Early Detection Matters More Than Ever
Families and loved ones have more reason than ever to prioritize early detection. While there is still no cure for Alzheimer’s disease, some medications, including lecanemab (approved in 2023) and others in clinical trials, are designed to slow progression when started in the earliest stages of memory loss.
Beyond medical treatments, early diagnosis allows loved ones to:
- Create a care plan together
- Explore supportive services like memory care programs
- Make lifestyle changes that may help preserve cognitive health
- Access caregiver resources and education sooner
Limitations of the SAGE Test
While helpful, the SAGE test is not diagnostic. Results alone cannot confirm Alzheimer’s or another dementia. Only a doctor can provide an accurate diagnosis using a combination of medical history, neurological exams, imaging like MRIs, and blood tests for Alzheimer’s biomarkers.
It’s also important to note that not all memory changes signal dementia. Stress, depression, medications, and normal aging can all cause forgetfulness.
How Does SAGE Compare to Other Cognitive Tests?
SAGE is just one of several screening options for cognitive decline. Here’s how it stacks up against other commonly used tests:
- MoCA (Montreal Cognitive Assessment):
The MoCA evaluates many of the same skills as SAGE, but must be administered by a clinician. It’s considered highly sensitive to mild cognitive impairment. It’s used quite commonly in clinical settings. - MMSE (Mini-Mental State Examination):
A long-standing tool that screens for orientation, recall, and language. It’s faster to administer (5–10 minutes), but less sensitive to early decline than MoCA or SAGE. - Mini-Cog:
A brief 3–5 minute tool combining recall and clock drawing. The Mini-Cog is useful in primary care, but limited in scope compared to more detailed tests.
Key Differences:
- Self vs. clinician-administered: SAGE is unique in being self-administered, while others are guided by a healthcare provider.
- Detail and sensitivity: SAGE and MoCA provide broader insights and are more effective at detecting early impairment than MMSE.
- Speed: Mini-Cog and MMSE are quicker but less comprehensive.
No single test is definitive. Instead, they act as screening tools to determine if further evaluation is needed.
Using the SAGE Test as a Tool
If you or a loved one decide to take the SAGE test, use it as a starting point for discussion with a doctor. Families can also keep a written log of everyday memory lapses, mood changes, or functional difficulties to share during appointments. This context helps doctors make more accurate evaluations.
Support for Loved Ones and Caregivers
Navigating a potential memory loss diagnosis can feel overwhelming. That’s why resources beyond the doctor’s office are so important. At Bridges® by EPOCH, we offer caregiver support groups where families can connect and share experiences. We also provide educational events led by dementia care professionals, providing tools and knowledge to help at home.
Of course, if you decide it is time for specialized assisted living and support, our memory care communities are designed to provide a safe, engaging, and dignified lifestyle for those living with Alzheimer’s disease and related dementias
These supports help ensure that loved ones are not alone in their journey.
Compassionate Care for Every Stage of Dementia
Bridges® by EPOCH communities are built exclusively for memory care. Our purpose-built designs, compassionate teams, and wellness-focused programming ensure that residents live with dignity, comfort, and socialized engagement at every stage of memory loss.
If you’re concerned about memory changes in yourself or a loved one, consider discussing the SAGE test with your physician and connecting with local memory care resources.
Contact us today to learn more.